DEVELOPMENT OF POSITIVE ALLOSTERIC MODULATORS OF NICOTINIC RECEPTORS FOR THE TREATMENT OF ALCOHOLISM

被引:0
|
作者
Wang, J. [1 ,2 ,3 ]
Lindstrom, J. [1 ,2 ,3 ]
Kamenecka, T. M. [1 ,2 ,3 ]
Kenny, P. J. [1 ,2 ,3 ]
Messing, R. O. [1 ,2 ,3 ]
机构
[1] Univ Texas Austin, Div Pharmacol & Toxicol, Austin, TX 78712 USA
[2] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA
[3] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
372
引用
收藏
页码:110A / 110A
页数:1
相关论文
共 50 条
  • [1] Flavonoids as positive allosteric modulators of α7 nicotinic receptors
    Elizabeth Nielsen, Beatriz
    Bermudez, Isabel
    Bouzat, Cecilia
    [J]. NEUROPHARMACOLOGY, 2019, 160
  • [2] Establishment of HTS assays for measurement of positive allosteric modulators of nicotinic α7 receptors
    Christensen, Jeppe K.
    Loechel, Frosty
    Jorgensen, Susanne
    Ahring, Philip K.
    Jensen, Marianne L.
    Timmermann, Daniel B.
    Peters, Dan
    Olsen, Gunnar M.
    Dyhring, Tino
    [J]. BIOCHEMICAL PHARMACOLOGY, 2007, 74 (08) : SMA15 - SMA15
  • [3] Functional insight into development of positive allosteric modulators of AMPA receptors
    Weeks, Autumn M.
    Harms, Jonathan E.
    Partin, Kathryn M.
    Benveniste, Morris
    [J]. NEUROPHARMACOLOGY, 2014, 85 : 57 - 66
  • [4] The effects of positive allosteric modulators of α7 nicotinic receptors on rats' performance in the odour span test
    Potasiewicz, A.
    Nikiforuk, A.
    Popik, P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S46 - S46
  • [5] Chalcones as positive allosteric modulators of α7 nicotinic acetylcholine receptors: A new target for a privileged structure
    Balsera, Beatriz
    Mulet, Jose
    Fernandez-Carvajal, Asia
    de la Torre-Martinez, Roberto
    Ferrer-Montiel, Antonio
    Hernandez-Jimenez, Jose G.
    Estevez-Herrera, Judith
    Borges, Ricardo
    Freitas, Andiara E.
    Lopez, Manuela G.
    Teresa Garcia-Lopez, M.
    Gonzalez-Muniz, Rosario
    Perez de Vega, Maria Jesus
    Valor, Luis M.
    Svobodova, Lucie
    Sala, Salvador
    Sala, Francisco
    Criado, Manuel
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 86 : 724 - 739
  • [6] Characterization of type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors
    Young, Gareth T.
    Millar, Neil S.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2009, 78 (07) : 914 - 914
  • [7] Should allosteric positive modulators of GABAA receptors be tested in the treatment of schizophrenia?
    Costa, E
    Guidotti, A
    Veldic, M
    [J]. SCHIZOPHRENIA RESEARCH, 2005, 73 (2-3) : 367 - 368
  • [8] Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment
    Ellaithy, Amr
    Younkin, Jason
    Gonzalez-Maeso, Javier
    Logothetis, Diomedes E.
    [J]. TRENDS IN NEUROSCIENCES, 2015, 38 (08) : 506 - 516
  • [9] Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer's Disease
    Forsell, Pontus
    Fernandez, Cristina Parrado
    Nilsson, Boel
    Sandin, Johan
    Nordvall, Gunnar
    Segerdahl, Maerta
    [J]. PHARMACEUTICALS, 2024, 17 (08)
  • [10] TWO BIRDS WITH ONE STONE: ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS FOR THE TREATMENT OF AUD
    Wang, J.
    Chapman, H. L.
    Lindstrom, J.
    Kamenecka, T. M.
    Kenny, P. J.
    Messing, R. O.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 291A - 291A